News Conference News TCT 2025 More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain Yael L. Maxwell October 26, 2025
News Conference News ESC 2025 ESC/EACTS Release New Valvular Heart Disease Guidelines Yael L. Maxwell September 03, 2025
News Conference News STS 2025 Surgeons: Be Active in Tricuspid Procedures or Be ‘Left Behind’ Yael L. Maxwell February 05, 2025
News Conference News THT 2023 Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry Caitlin E. Cox March 21, 2023
News Conference News PCR London Valves 2022 Big Gains in Function, QoL With Transcatheter TV Replacement: TRISCEND Registry Shelley Wood November 28, 2022
News Conference News TCT 2022 Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID Michael O'Riordan September 17, 2022
News Conference News TCT 2021 Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward Yael L. Maxwell November 06, 2021
News Conference News TVT 2021 Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market Todd Neale July 22, 2021
News Conference News EuroPCR 2021 Tricuspid Trio: TRISCEND, CLASP TR, and TriBAND Studies Show Advances Caitlin E. Cox May 21, 2021
News Daily News Structural Heart Interventions in the Midst of COVID-19: Today’s Advice, Tomorrow’s Unknowns Shelley Wood April 13, 2020
News Daily News Cardiac Rehab Tied to Fewer Hospitalizations, Deaths After Valve Surgery Todd Neale October 23, 2019
News Conference News EHRA 2019 Thromboembolic Risks High in Patients With A-fib, Valvular Disease Todd Neale March 25, 2019
News Conference News TCT 2018 More Evidence That the MitraClip Might Be Useful in the Tricuspid Valve Todd Neale September 24, 2018
News Daily News Isolated Tricuspid Valve Surgery Remains Rare and Risky Caitlin E. Cox December 13, 2017
News Conference News TCT 2017 For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results Yael L. Maxwell November 02, 2017
News Industry News NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR) August 30, 2017